RMTI
Rockwell Medical Inc
8.70$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 106.1% | 94.3% | 80.6% | 81.8% | 89.9% | 87.4% | 82.9% | 84.4% | 89.1% | 90.2% | 93.0% | 94.2% | 85.6% | 83.4% | 88.5% | 86.6% | 87.3% | 84.2% | 83.9% | 87.3% | 93.5% | 102.5% | 95.4% | 95.6% | 103.9% | 94.4% | 89.6% | 82.8% | 83.1% | |
| -6.1% | 5.7% | 19.4% | 18.2% | 10.1% | 12.6% | 17.1% | 15.6% | 10.9% | 9.8% | 7.0% | 5.8% | 14.4% | 16.6% | 11.5% | 13.4% | 12.7% | 15.8% | 16.1% | 12.7% | 6.5% | -2.5% | 4.6% | 4.4% | -3.9% | 5.6% | 10.4% | 17.2% | 16.9% | |
| – | – | – | – | – | 1.0% | 1.7% | 1.1% | 1.3% | 16.7% | 7.6% | 7.4% | 11.8% | 5.7% | 36.4% | 96.8% | 75.2% | 14.4% | 9.0% | 11.0% | 11.0% | 10.6% | 11.2% | 11.4% | 11.0% | 4.3% | 1.3% | 0.0% | 0.0% | |
| – | – | – | 27.1% | 26.1% | 20.2% | 15.8% | 13.4% | 10.4% | 26.0% | 7.8% | 14.1% | 12.6% | 15.6% | 19.4% | 25.4% | 27.4% | 33.8% | 34.5% | 39.6% | 40.7% | 34.8% | 34.3% | 26.0% | 24.8% | 21.5% | 14.5% | 13.9% | 20,260.5% | |
| 51.5% | 43.4% | 35.8% | 32.2% | 26.1% | 20.1% | 15.8% | 13.4% | 10.4% | 26.0% | 15.4% | 21.5% | 24.4% | 21.4% | 55.8% | 122.3% | 102.6% | 48.2% | 43.4% | 50.6% | 51.7% | 47.1% | 60.2% | 50.1% | 45.1% | 28.6% | 18.4% | 16.6% | 23.7% | |
| -57.6% | -37.7% | -16.4% | -14.0% | -16.0% | -7.5% | 1.3% | 2.3% | 0.5% | -16.2% | -8.4% | -15.6% | -10.0% | -4.8% | -44.3% | -108.9% | -89.8% | -32.4% | -27.3% | -37.9% | -45.2% | -51.2% | -55.6% | -45.7% | -49.0% | -23.0% | -8.0% | 0.6% | -6.8% | |
| 0.0% | 1.9% | 0.0% | 0.0% | 1.0% | 1.0% | 1.2% | 1.1% | 0.7% | 0.0% | 0.3% | 15.6% | 0.0% | 0.0% | 0.0% | 0.0% | 3.5% | 7.7% | 27,284.8% | 37,926.3% | 45,240.5% | 0.0% | 0.0% | 3.0% | 3.8% | 2.7% | 2.8% | 1.2% | 1.6% | |
| – | – | – | – | -17.5% | -8.5% | 0.0% | 1.2% | 0.3% | -16.0% | -8.6% | -15.2% | -10.1% | -4.5% | -43.8% | -108.4% | -93.1% | -39.4% | -26.1% | -36.4% | -45.2% | -50.7% | -60.6% | -49.7% | -52.8% | -25.7% | -10.1% | -0.5% | -7.7% | |
| – | -1.9% | – | -0.4% | 1.5% | 1.0% | – | – | 0.2% | – | – | – | – | -0.3% | 0.0% | 0.5% | 0.2% | 0.7% | 0.0% | 0.8% | 0.0% | 0.5% | -5.0% | 1.7% | 3.8% | 2.6% | 1.5% | – | – | |
| -57.6% | -35.8% | -16.4% | -13.6% | -17.5% | -8.5% | 0.0% | 1.2% | 0.3% | -16.0% | -8.6% | -15.2% | -10.1% | -4.5% | -43.8% | -108.4% | -93.1% | -39.4% | -26.1% | -37.2% | -45.2% | -50.7% | -55.7% | -49.7% | -52.8% | -25.7% | -10.1% | -0.5% | -7.7% | |
| -48.5% | -26.4% | -10.4% | -8.9% | -11.7% | -4.1% | 4.3% | 5.8% | 2.6% | -13.3% | -6.2% | -13.5% | -7.8% | -2.2% | -41.4% | -106.2% | -87.7% | -29.9% | -24.6% | -35.0% | -44.3% | -49.7% | -51.3% | -43.0% | -44.9% | -22.2% | -5.6% | 2.9% | -2.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.